UBS Group AG - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$314,000
-80.5%
11,386
-88.3%
0.00%
-100.0%
Q1 2021$1,608,000
+2452.4%
97,560
+2756.8%
0.00%
Q4 2020$63,000
-85.7%
3,415
-89.4%
0.00%
Q3 2020$440,000
-23.9%
32,305
+0.1%
0.00%
Q2 2020$578,000
+159.2%
32,278
+44.3%
0.00%
Q1 2020$223,000
-44.5%
22,375
-54.7%
0.00%
Q4 2019$402,000
+171.6%
49,417
+230.6%
0.00%
Q3 2019$148,000
+1245.5%
14,949
+1669.1%
0.00%
Q2 2019$11,000
-54.2%
845
-64.3%
0.00%
Q3 2018$24,0002,3700.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders